Clinical Evaluation of Endoxan on Malignant Tumors in Otorhinolaryngology

Abstract

23 cases of the malignant diseases were treated with various combination methods, namely a new alkylating agent “Endoxan” and other local treatments.
1. Cases which used combination methods were the most successful, especially as were administered before, between and after operation. These methods were more effective for sarcomas than carcinomas.
2. Side-effects were fewer and slighter than another antitumor agents.